The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 245.00
Bid: 245.00
Ask: 246.00
Change: -1.50 (-0.61%)
Spread: 1.00 (0.408%)
Open: 246.00
High: 246.00
Low: 243.50
Prev. Close: 246.50
GRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Director of Land and Development

20 Feb 2018 07:00

RNS Number : 3195F
Grainger PLC
20 February 2018
 

 

20 February 2018

 

Grainger plc

 

 

Appointment of Director of Land and Development

 

 

Grainger plc, the UK's largest listed residential landlord, today announces that it has appointed Mike Keaveney as Director of Land and Development.

 

Mike Keaveney has over 29 years of hands-on real estate and development experience. His expertise includes management of complex residential-led mixed use developments across the whole development lifecycle from identification and acquisition through to town planning, funding, construction, marketing, operation and exit.

 

Mike's appointment further strengthens Grainger's development capability to support its growth plans. Grainger currently has 10 private rented sector (PRS) build to rent development projects underway through both direct development and forward funding and plans to continue its growth trajectory through further acquisitions and developments. Mike Keaveney will hold overall responsibility for the delivery and growth of Grainger's development pipeline.

 

Mike Keaveney will report into Helen Gordon, Chief Executive, and he will work closely alongside Grainger's Director of Investment, Andrew Saunderson, and Grainger's Chief Operating Officer, John Kenny.

 

Reporting into Mike Keaveney will be Paul McGowan, Director of Land, who joined Grainger at the beginning of the year and who is responsible for identifying new land acquisition opportunities, and Mark Woodrow, Director of Development.

 

Prior to joining Grainger, Mike Keaveney was Development Director at Concord London Developments Ltd, working for Concord Pacific, Canada's largest community builder. Most recently he led on the acquisition of the Moxon Street car park site in Marylebone from Westminster City Council with a gross development value of £300m and was instrumental in the joint venture with Brookfield to develop out the 50 storey residential tower and affordable housing blocks at Principal Place in London EC1.

 

Mike's early career was at Osprey PMI (part of Franklin + Andrews; now Mott MacDonald) where he was an Equity Partner and Board Director responsible for the London Office of Osprey PMI and its Commercial Development projects in the UK prior to moving to Ridgeford Developments Ltd and W1 Developments.

 

Mike Keaveney is expected to join Grainger in April.

 

Helen Gordon, Chief Executive, said:

 

"I am pleased to announce the appointment of Mike Keaveney as Grainger's Director of Land and Development. Mike brings with him extensive experience of both acquiring and delivering great development opportunities, particularly in the residential sector. Mike will be a welcome addition to our team as we continue to grow Grainger's PRS portfolio."

 

 

-ENDS-

For further information:

 

Grainger plc

Kurt Mueller

London Office Tel: +44 (0) 20 7940 9500

 

Camarco (Financial PR adviser)

Ginny Pulbrook / Geoffrey Pelham-Lane

+44 (0) 20 3757 4992/4985

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAXANFAEPEFF
Date   Source Headline
13th Dec 20221:46 pmRNSDirector/PDMR Shareholding
8th Dec 202210:36 amRNSDirectorate Change
7th Dec 20221:33 pmRNSDirector/PDMR Shareholding
6th Dec 202211:47 amRNSTotal Voting Rights
21st Nov 20221:12 pmRNSDividend Declaration
17th Nov 20227:00 amRNSFinal Results
14th Nov 20227:00 amRNSBoard Appointment
7th Nov 20222:47 pmRNSDirector/PDMR Shareholding
11th Oct 20223:00 pmRNSDirector/PDMR Shareholding
6th Oct 20223:12 pmRNSBlock listing Interim Review
29th Sep 20223:20 pmRNSDirector/PDMR Shareholding
29th Sep 202211:08 amRNSTotal Voting Rights
20th Sep 20221:23 pmRNSDirector Declaration
12th Sep 20227:00 amRNSTRADING UPDATE
12th Sep 20227:00 amRNSTrading Update
7th Sep 20222:31 pmRNSTotal Voting Rights
6th Sep 202212:29 pmRNSDirector/PDMR Shareholding
17th Aug 20222:49 pmRNSHolding(s) in Company
8th Aug 20222:34 pmRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSCapital Markets Event
4th Jul 20223:33 pmRNSHolding(s) in Company
23rd Jun 20227:00 amRNSAcquisition
14th Jun 20222:22 pmRNSAdditional Listing
8th Jun 20223:06 pmRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSHolding(s) in Company
12th May 20227:00 amRNSHalf Year Financial Results
6th May 202210:48 amRNSDirector/PDMR Shareholding
21st Apr 20222:15 pmRNSHolding(s) in Company
7th Apr 202212:01 pmRNSDirector/PDMR Shareholding
1st Apr 202212:08 pmRNSBlock listing Interim Review
25th Mar 20227:00 amRNSNotice of Interim Results
7th Mar 202212:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202212:12 pmRNSTotal Voting Rights
3rd Mar 202212:08 pmRNSHolding(s) in Company
18th Feb 202211:07 amRNSDirector/PDMR Shareholding
9th Feb 20224:00 pmRNSResult of AGM
9th Feb 20227:00 amRNSTrading Update
8th Feb 202210:10 amRNSDirector/PDMR Shareholding
4th Feb 202212:26 pmRNSTotal Voting Rights
4th Feb 202212:26 pmRNSDirector/PDMR Shareholding
26th Jan 202211:47 amRNSHolding(s) in Company
11th Jan 20221:13 pmRNSAGM Statement
10th Jan 202211:43 amRNSDirector/PDMR Shareholding
20th Dec 202110:26 amRNSDirector/PDMR Shareholding
20th Dec 202110:20 amRNSDirector/PDMR Shareholding
6th Dec 202111:31 amRNSDirector/PDMR Shareholding
24th Nov 202110:03 amRNSEBT purchase
23rd Nov 20217:00 amRNSGrainger Trust Board Changes
22nd Nov 20217:00 amRNSDirector of Investment Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.